| Dr Lloyd Patterson Walton Claycomb, MD | |
|
1218 W Mcdermott Dr, Allen, TX 75013-6304 | |
| (972) 390-9000 | |
| (972) 396-5173 |
| Full Name | Dr Lloyd Patterson Walton Claycomb |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1218 W Mcdermott Dr, Allen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326025388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M2862 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lloyd Patterson Walton Claycomb, MD Po Box 9101, Coppell, TX 75019-9494 Ph: (972) 745-7500 | Dr Lloyd Patterson Walton Claycomb, MD 1218 W Mcdermott Dr, Allen, TX 75013-6304 Ph: (972) 390-9000 |
News Archive
A home-based program to improve exercise and diet led to significant, clinically meaningful improvement in body weight and physical function among older long-term cancer survivors in preliminary findings from the RENEW (Reach-out to ENhancE Wellness) trial, according to Wendy Demark-Wahnefried, Ph.D., from The University of Texas M. D. Anderson Cancer Center's Department of Behavioral Science.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, will be presented during the 22nd Annual Symposium of EORTC-NCI-AACR being held November 16-19, 2010 in Berlin, Germany.
He urged police chiefs to redouble their efforts and make sure that new measures and resources are being used. Tools to help the police do their job include the Criminal Justice Interventions Programme which targets offenders who commit crimes to fund their drug habit. It is receiving £447m funding over three years.
STERIS Corporation today announced financial results for its fiscal 2010 second quarter ended September 30, 2009. Fiscal 2010 second quarter revenues were $314.2 million compared with $323.1 million in the second quarter of fiscal 2009, a decline of 3%.
› Verified 7 days ago
Dr. Astrid Gutsmann, DO, PH.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 411 E Mcdermott Dr, Allen, TX 75002 Phone: 972-227-3464 Fax: 972-359-9690 | |
Sovannarat Floyd, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 W Mcdermott Dr Ste 124, Allen, TX 75013 Phone: 469-564-1026 | |
Dr. Sadaf Sadruddin Sabzali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 E Stacy Rd Ste 160, Allen, TX 75002 Phone: 214-726-9098 Fax: 972-727-0842 | |
Dr. Nicholas Owon Kpar Atudonyang, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 977 Raintree Cir, Suite 210, Allen, TX 75013 Phone: 214-865-6648 Fax: 214-865-6646 | |
Wallace B Sarver, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 E Stacy Rd Ste 160, Allen, TX 75002 Phone: 214-726-9098 Fax: 972-727-0842 | |
Dr. Jeffrey L Burchard, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1105 Central Expy N, Ste 110, Allen, TX 75013 Phone: 972-727-9877 Fax: 972-727-5015 | |
Oyindamola Ojuolape Wemimo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1218 W Mcdermott Dr, Allen, TX 75013 Phone: 972-390-9000 |